Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Profit After Tax: 2021-2025

Historic Profit After Tax for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$177,000.

  • Immunocore Holdings' Profit After Tax fell 102.03% to -$177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 37.88%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
  • Latest data reveals that Immunocore Holdings reported Profit After Tax of -$177,000 as of Q3 2025, which was up 98.28% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Profit After Tax ranged from a high of $8.7 million in Q3 2024 and a low of -$36.5 million during Q4 2022.
  • In the last 3 years, Immunocore Holdings' Profit After Tax had a median value of -$11.6 million in 2024 and averaged -$10.2 million.
  • As far as peak fluctuations go, Immunocore Holdings' Profit After Tax surged by 864.24% in 2024, and later slumped by 102.03% in 2025.
  • Over the past 4 years, Immunocore Holdings' Profit After Tax (Quarterly) stood at -$36.5 million in 2022, then soared by 45.98% to -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then crashed by 102.03% to -$177,000 in 2025.
  • Its Profit After Tax was -$177,000 in Q3 2025, compared to -$10.3 million in Q2 2025 and $5.0 million in Q1 2025.